David Donabedian

David Donabedian is the founder of Newleos Therapeutics. Newleos Therapeutics has raised $93M, most recent round: Series A (2025). Biotech · Boston, MA.

About David Donabedian

David Donabedian is the founder of Newleos Therapeutics. Newleos Therapeutics operates in Biotech and is based in Boston, MA. Newleos Therapeutics has raised $93M, most recent round: Series A (2025). Backers on record include Kasim Kutay, Novo Holdings.

David Donabedian at a glance

Company
Newleos Therapeutics
Industry
Biotech
Location
Boston, MA
Total raised
$93M
Investors on record
Kasim Kutay, Novo Holdings

Frequently asked about David Donabedian

Who is David Donabedian?
David Donabedian is the founder of Newleos Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did David Donabedian found?
David Donabedian founded Newleos Therapeutics, a Biotech company based in Boston, MA.
How do I contact David Donabedian?
Verified contact routes including LinkedIn, background and funding history for David Donabedian are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in Boston — who backed them, at what stage, and how much they raised.

More Biotech founders (40)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library